Filing Details

Accession Number:
0000874015-19-000061
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-04-17 19:30:59
Reporting Period:
2019-04-15
Accepted Time:
2019-04-17 19:30:59
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
874015 Ionis Pharmaceuticals Inc IONS Pharmaceutical Preparations (2834) 330336973
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
897667 T Stanley Crooke C/O Ionis Pharmaceuticals, Inc.
2855 Gazelle Court
Carlsbad CA 92010
Chairman And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-04-15 10,000 $14.69 79,634 No 4 M Direct
Common Stock Disposition 2019-04-15 10,000 $85.25 69,634 No 4 S Direct
Common Stock Acquisiton 2019-04-15 1,000 $10.82 6,532 No 4 M Indirect By wife
Common Stock Disposition 2019-04-15 1,000 $85.25 5,532 No 4 S Indirect By wife
Common Stock Acquisiton 2019-04-16 6,680 $14.69 76,314 No 4 M Direct
Common Stock Disposition 2019-04-16 6,680 $84.75 69,634 No 4 S Direct
Common Stock Acquisiton 2019-04-16 13,320 $39.87 82,954 No 4 M Direct
Common Stock Disposition 2019-04-16 13,320 $84.56 69,634 No 4 S Direct
Common Stock Acquisiton 2019-04-16 300 $10.82 5,832 No 4 M Indirect By wife
Common Stock Disposition 2019-04-16 300 $84.75 5,532 No 4 S Indirect By wife
Common Stock Acquisiton 2019-04-16 700 $39.87 6,232 No 4 M Indirect By wife
Common Stock Disposition 2019-04-16 700 $84.75 5,532 No 4 S Indirect By wife
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Indirect By wife
No 4 S Indirect By wife
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Indirect By wife
No 4 S Indirect By wife
No 4 M Indirect By wife
No 4 S Indirect By wife
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Disposition 2019-04-15 10,000 $0.00 10,000 $14.69
Common Stock Employee Stock Option (right to buy) Disposition 2019-04-15 1,000 $0.00 1,000 $10.82
Common Stock Employee Stock Option (right to buy) Disposition 2019-04-16 6,680 $0.00 6,680 $14.69
Common Stock Employee Stock Option (right to buy) Disposition 2019-04-16 13,320 $0.00 13,320 $39.87
Common Stock Employee Stock Option (right to buy) Disposition 2019-04-16 300 $0.00 300 $10.82
Common Stock Employee Stock Option (right to buy) Disposition 2019-04-16 700 $0.00 700 $39.87
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
6,680 2017-01-02 2020-01-29 No 4 M Direct
300 2017-01-02 2020-01-01 No 4 M Indirect
0 2017-01-02 2020-01-29 No 4 M Direct
57,180 2018-01-02 2021-01-01 No 4 M Direct
0 2017-01-02 2020-01-01 No 4 M Indirect
2,500 2018-01-02 2021-01-01 No 4 M Indirect
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 725,391 Indirect By trust
Footnotes
  1. Acquired as a result of exercising a stock option pursuant to Rule 10b5-1 Trading Plan. The purchase and sale reported on this Form 4 was effective pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on 3/13/2019.
  2. Acquired as a result of exercising a stock option pursuant to Rule 10b5-1 Trading Plan. The purchase and sale reported on this Form 4 was effective pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person's wife on 3/13/2019.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.50 to $84.75, inclusive. The reporting person undertakes to provide to Ionis Pharmaceuticals, Inc., any security holder of Ionis Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) on this Form 4.